Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples